Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022

SELL
$463.67 - $597.16 $25,038 - $32,246
-54 Reduced 11.23%
427 $211,000
Q1 2022

May 09, 2022

BUY
$524.57 - $735.42 $15,212 - $21,327
29 Added 6.42%
481 $271,000
Q4 2021

Feb 10, 2022

BUY
$708.84 - $794.68 $708 - $794
1 Added 0.22%
452 $297,000
Q3 2021

Oct 20, 2021

SELL
$657.71 - $825.77 $657 - $825
-1 Reduced 0.22%
451 $335,000
Q2 2021

Jul 21, 2021

SELL
$576.64 - $649.04 $2,883 - $3,245
-5 Reduced 1.09%
452 $297,000
Q1 2021

Apr 28, 2021

BUY
$547.01 - $662.35 $9,299 - $11,259
17 Added 3.86%
457 $275,000
Q4 2020

Jan 26, 2021

SELL
$510.68 - $643.45 $17,363 - $21,877
-34 Reduced 7.17%
440 $256,000
Q3 2020

Nov 09, 2020

BUY
$454.43 - $535.6 $14,087 - $16,603
31 Added 7.0%
474 $253,000
Q2 2020

Jul 17, 2020

BUY
$334.87 - $493.06 $148,347 - $218,425
443 New
443 $200,000
Q4 2018

Feb 07, 2019

SELL
$220.1 - $309.0 $6,603 - $9,270
-30 Closed
0 $0
Q3 2018

Nov 19, 2018

BUY
$289.28 - $326.15 $8,678 - $9,784
30 New
30 $8,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.1B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Csenge Advisory Group Portfolio

Follow Csenge Advisory Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Csenge Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Csenge Advisory Group with notifications on news.